CARB-X Funding Rounds Q&A 2023
OnlineRegister for the 1st of 2 Q&A sessions on the upcoming CARB-X funding rounds: Webinar Registration – Zoom. To register for the 2nd of 2 Q&A sessions please visit the site here.
Register for the 1st of 2 Q&A sessions on the upcoming CARB-X funding rounds: Webinar Registration – Zoom. To register for the 2nd of 2 Q&A sessions please visit the site here.
Fourteen partners attended this second meeting of the Machine Learning (ML) Scientific Interest Group (SIG), which focused on the practical application of Artificial Intelligence (AI) and Machine Learning methods in antimicrobial drug discovery (ADD). Artificial intelligence concerns the study and development of machines that are capable of learning and problem-solving, thus natural intelligence. A "worked […]
About ten people attended this second meeting with the Scientific Interest Group (SIG) on animal models. As a follow up from the previous SIG meeting, this event focused on “Data Cataloging of animal infection models.”. The attendees contributed to this first version of the in vivo catalog with information about their resources and infection models […]
Please save the date for the 2023 Antimicrobial Chemotherapy Conference. This free to attend virtual conference is organized by GARDP and BSAC in collaboration with ReACT Africa.
The 4th AMR Accelerator Cross-project Meeting for the AMR Accelerator community, a total of 9 projects, took place on 15 Mach 2023 at the Marriott Hotel, Basel, Switzerland. Agenda: List of registered participants
People affected with bacterial infections can be involved in every step of antibiotic drug development. Not only can they be receiving an antibiotic treatment that derives from research results, but they can also be contributing partners of research, and even involved in further research. During this Science Communication Interest Group meeting, we explored community engagement […]
Please save the date for the upcoming 7th AMR Conference 2023! The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market. To stay informed visit the website here.